Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.93 USD | +0.61% | -6.71% | -30.47% |
Financials (USD)
Sales 2024 * | 385M | Sales 2025 * | 257M | Capitalization | 5.19B |
---|---|---|---|---|---|
Net income 2024 * | -451M | Net income 2025 * | -551M | EV / Sales 2024 * | 16.4 x |
Net Debt 2024 * | 1.1B | Net Debt 2025 * | 1.5B | EV / Sales 2025 * | 26 x |
P/E ratio 2024 * |
-10.7
x | P/E ratio 2025 * |
-9.22
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.93% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | -5.16% | ||
1 week | -10.57% | ||
Current month | +8.35% | ||
1 month | +9.03% | ||
3 months | -18.35% | ||
6 months | -5.90% | ||
Current year | -31.24% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 28.02 | +0.95% | 304 776 |
24-05-23 | 27.76 | -5.16% | 1,856,313 |
24-05-22 | 29.27 | -0.03% | 992,715 |
24-05-21 | 29.28 | -0.81% | 2,419,205 |
24-05-20 | 29.52 | -1.89% | 1,515,924 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.24% | 5.19B | |
-2.13% | 90.27B | |
+1.32% | 40.12B | |
-15.73% | 31.75B | |
+64.13% | 26.6B | |
-21.28% | 14.41B | |
-8.50% | 12.92B | |
-44.07% | 11.3B | |
-13.06% | 11.44B | |
+4.94% | 8.87B |
- Stock Market
- Equities
- BBIO Stock